TP53 and colorectal carcinoma: Results of immunohistochemical staining showed that increased TP53 missense mutations occurred in the positive mSEPT9 group, indicating that hypermethylation of CpG island of SEPT9 may promote TP53 missense mutations in patients with CRC (Figure 2A c and d).